If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00
  • There is currently no data for TET

Trading Update

15 Aug 2022 07:00

RNS Number : 9405V
Treatt PLC
15 August 2022
 

15 August 2022

TREATT PLC

("Treatt" or "the Group")

Trading Update

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces a trading update for the year ending 30 September 2022.

In the Group's half year results announcement, we referenced the anticipated return to Treatt's traditional H2 profit weighting supported by a very strong order book. Although the Group is still expecting to report strong revenue growth for the full year and retains an excellent order book, it has been affected by a number of separate factors which will impact profitability for the full year. We now expect profit before tax and exceptional items to be between £15.0m and £15.3m.

The revised guidance is given for the following reasons:

· As stated in the half year results, we anticipated a much stronger performance from our higher margin Tea category in H2 driven by iced and hard tea consumption in North America. As has been well-documented, consumer confidence in the US has deteriorated in recent months causing lower demand in this category which has materially reduced our margins. Whilst Tea sales will be lower year-on-year, after an exceptional FY21 performance, our anticipated two year growth of over 60% in this category highlights the significant opportunity in the future.

 

· The Group's margins have been adversely affected by increasing volatility in FX movements during H2. The UK business makes a portion of its sales in US Dollars and uses foreign currency exchange contracts to manage risk. The rapid devaluation of Sterling against the US Dollar during the period has had a significant impact on margins.

 

· The Group is experiencing significant input cost inflation and whilst, in a number of cases, the business has been able to pass this onto its customers, some longer term contracts have not yet allowed this to be achieved across the full portfolio.

 

· Our China subsidiary has experienced well documented extended Covid-19 related restrictions in large parts of the region resulting in the loss of some higher margin revenue in the year.

Notwithstanding these negative, predominantly short-term, challenges to profitability, we are encouraged by other trends seen through H2, including the ongoing strength of the order book which, as announced in the half year results, continues to be up c.25% year-on-year, giving us confidence as we head towards the new financial year. Aside from the Tea category, we are seeing strong growth in all other Treatt categories and the opportunity for efficiencies in our new UK manufacturing site is increasingly clear.

After substantial investment in our people over the past 12-18 months, we believe we now have the right people infrastructure in place to seize the multiple growth opportunities available; we do not anticipate any significant increase in administrative expenses in the short to medium term, outside of the normal rate of inflation. The Company is also reviewing how it can better limit FX exposure in light of increasing volatility.

Daemmon Reeve, CEO of Treatt, commented:

"Whilst clearly disappointed by the short term impact on profitability, we remain encouraged by the underlying trading performance of the business and are confident in the long term growth drivers for Treatt.

We have significant opportunities across our categories and geographies and, notwithstanding the short-term impacts in Tea, we see strong momentum in all of our categories given the alignment with prevailing consumer trends. For example, there continues to be sustained growth in demand for our natural and authentic extracts and bespoke solutions for a wide range of beverages.

We also remain excited about the potential in Coffee over the next few years and expect this category to be reported separately at the full year given we are now seeing growth in orders and multiple opportunities for the future."

Financial calendar

The Group expects to issue a trading update in October 2022, after the completion of the financial year to 30 September 2022.

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Ryan Govender Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Andrew Clark

Lalit Bose

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

This announcement contains inside information within the meaning of the Market Abuse Regulation. The person responsible for arranging release of this announcement on behalf of Treatt is Ryan Govender, Chief Financial Officer.

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 400 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVLTEISLIF
Date   Source Headline
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Nov 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20227:10 amRNSFull Year Results
10th Nov 20227:00 amRNSNotice of Results
9th Nov 20228:50 amRNSChange of Company Secretary and Director’s Duties
1st Nov 20224:26 pmRNSDirectorate Change - Replacement
1st Nov 202210:05 amRNSBoard Change
17th Oct 20222:36 pmRNSHoling(s) in Company
17th Oct 20222:36 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
16th Sep 20222:28 pmRNSBoard Committee Changes
1st Sep 202210:39 amRNSNotification of Transaction of a Director
31st Aug 20222:37 pmRNSNotification of Transactions of Director
16th Aug 202211:33 amRNSNotification of Transactions of Director
16th Aug 202211:30 amRNSNotification of Transactions of Director
15th Aug 202211:40 amRNSNotification of Transactions of Director
15th Aug 202211:37 amRNSNotification of Transactions of Director
15th Aug 20227:00 amRNSTrading Update
9th Aug 20223:25 pmRNSHolding(s) in Company
14th Jul 20226:23 pmRNSNotification of Transactions of Director
11th Jul 20227:00 amEQSTreatt (TET): New facility to drive growth
24th Jun 20221:15 pmRNSChairman Succession and Board Change
23rd Jun 202210:04 amRNSDirector Declaration
22nd Jun 20227:00 amRNSVoting Rights and Capital
21st Jun 20222:43 pmRNSHolding(s) in Company
20th Jun 20225:25 pmRNSNotification of Transactions of Director
20th Jun 20225:22 pmRNSNotification of Transactions of Director
8th Jun 20224:50 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st May 20222:54 pmRNSHolding(s) in Company
27th May 20227:00 amRNSCapital Markets Day
19th May 20225:03 pmRNSHolding(s) in Company
17th May 202211:50 amRNSHolding(s) in Company
13th May 20224:37 pmRNSHolding(s) in Company
13th May 20224:37 pmRNSNotification of Transactions of Director
12th May 20226:17 pmRNSHolding(s) in Company
12th May 20225:07 pmRNSHolding(s) in Company
12th May 202212:09 pmRNSNotification of Transactions of Director
11th May 20224:24 pmRNSHolding(s) in Company
11th May 20223:18 pmRNSNotification of Transactions of Director
10th May 20227:00 amRNSHalf-year Report
27th Apr 202210:28 amRNSDirector Declaration
11th Apr 20227:00 amRNSHalf Year Trading Update and Notice of Results
1st Apr 20221:59 pmRNSVoting Rights and Capital
30th Mar 20223:00 pmRNSNotification of Transactions of Director
24th Mar 20225:02 pmRNSNotification of Transactions of a PCA
22nd Mar 20224:55 pmRNSNotification of Transactions of Directors & PCA
22nd Mar 20229:10 amRNSDirector Declaration
8th Mar 202211:09 amRNSStandard Form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.